PLOD1 is upregulated in osteosarcoma, gastric, breast, glioma, bladder, pancreatic, and hepatocellular cancers (HCCs), correlating with advanced tumor stages, metastasis, and reduced survival [96,97,98,99]. This evidence concerns the gene PLOD1 and central nervous system cancer.